Objective: The prognostic role of Klotho in patients with chronic kidney disease is still controversial. Therefore, we performed this meta-analysis to assess the relationship between the low sKlotho level and the risk of adverse kidney outcomes.
Materials And Methods: We systematically searched medical databases, such as PubMed, Embase, and the Cochrane Library, for eligible publications regarding the relationship between the low sKlotho level and risk of adverse kidney outcomes. The quality of included studies was assessed by using the Newcastle-Ottawa Scale. Combined hazard ratios (HRs) and its 95% confidence intervals (CIs) were calculated using a random- or fixed-effect model. Subgroup analysis was conducted with stratification by age, estimated glomerular filtration rate (eGFR), follow-up interval, region, and study quality. All data was analyzed by RevMan 5.3 analysis software.
Results: Eight cohort studies with 3586 participants from 3818 studies were included in our final analysis. Levels of sKlotho were significantly correlated with the eGFR, with a summary correlation coefficient and 95% CI of 0.469 (0.226, 0.658). Additionally, low sKlotho levels were strongly associated with increased adverse kidney outcomes, and the pooled HR and its 95% CI were 1.64 (1.19, 2.26; = 0.002), despite publication bias and statistical heterogeneity ( = 52%, = 0.07). Furthermore, this positive correlation was still observed in all of the subgroup analyses. However, heterogeneity was present in subgroup analyses stratified by the eGFR and follow-up interval.
Conclusion: Levels of sKlotho are positively correlated with the eGFR, and low sKlotho levels are significantly associated with an increased risk of poor kidney outcomes. Therefore, sKlotho could be used as a novel biomarker for early diagnosis and prognostic assessment for patients with chronic kidney disease. Studies with a larger sample size and longer follow-up period are warranted to validate our results.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589248 | PMC |
| http://dx.doi.org/10.1155/2019/6468729 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Anti-Inflammatory Role of the Klotho Protein and Relevance to Aging.
Cells
August 2024
Department of Endocrinology and Metabolism, Huashan Hospital, Shanghai Medical School, Fudan University, Shanghai 200030, China.
Article Synopsis
- The α-Klotho protein, produced mainly in the kidneys and brain, is essential for regulating fibroblast growth factor 23 (FGF23) and is linked to several chronic age-related diseases like diabetes and Alzheimer's through its anti-inflammatory properties.
- * Klotho exists in two forms: a membrane-bound form and a soluble form (s-Klotho), which interacts with various growth factor receptors and regulates major pathways, although its exact mechanisms of action are still being studied.
- * Low levels of Klotho are associated with increased inflammation, muscle loss, and fibrotic diseases, but s-Klotho can counteract these effects by inhibiting inflammatory pathways and promoting muscle repair.
Testosterone does not mediate the correlation between dietary inflammation and serum klotho levels among males: insights from NHANES database.
Front Endocrinol (Lausanne)
April 2024
Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Introduction: Serum Klotho (S-Klotho) is a transmembrane protein holds pivotal roles in anti-aging. The Dietary Inflammation Index (DII), a meticulously dietary tool, quantifies the inflammatory potential of an individual's diet. The existing research strongly suggests that a low DII diet plays a significant role in delaying aging and reducing aging-related symptoms in males.
View Article and Find Full Text PDFCorrelation between soluble klotho and chronic kidney disease-mineral and bone disorder in chronic kidney disease: a meta-analysis.
Sci Rep
February 2024
Department of Nephrology, The First Hospital of Jilin University, Changchun, China.
Article Synopsis
- A systematic search across multiple medical databases identified a total of 1944 individuals from 17 studies for analysis on the role of sKlotho in chronic kidney disease-related mineral and bone disorder (CKD-MBD).
- The study found significant correlations between sKlotho levels and various biochemical markers such as calcium, phosphate, and parathyroid hormone, suggesting low levels of sKlotho may increase CKD-MBD risk in patients.
- The research indicates that sKlotho could potentially help manage CKD-MBD by regulating mineral levels and reducing vascular calcification, but further high-quality studies are necessary for more definitive conclusions.
Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease-Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows.
Int J Mol Sci
February 2024
Metabolismo Óseo, Vascular y Enfermedades Inflamatorias Crónicas, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.
Shortly after the discovery of Klotho, interest grew in its potential role in chronic kidney disease (CKD). There are three isoforms of the Klotho protein: αKlotho, βKlotho and γKlotho. This review will focus on αKlotho due to its relevance as a biomarker in CKD.
View Article and Find Full Text PDFLower serum Klotho level and higher systemic immune-inflammation index: an inverse correlation.
BMC Geriatr
October 2023
Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University Medical School, Hangzhou, 310016, China.
Objectives: Klotho, an anti-aging protein, has been identified to control tissue inflammatory responses. The objective of this research is to determine the linkage between soluble Klotho (S-Klotho) level and systemic immune-inflammation index (SII).
Methods: Eligible participants with complete information of S-Klotho level and SII were selected from the National Health and Nutrition Examination Surveys (NHANES).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!